Retraction
Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
Paper Information
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9756164Additional Notes:
See also: https://pubpeer.com/publications/2C9B65EB23DB1DA47F54698DD7C986
Citations (5)
5
Total Citations0
Post-Retraction3
Pre-Retraction1
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
Applied Bionics And Biomechanics
Applied Bionics and Biomechanics
Open Access
Published: Oct 2023
Same day as retraction
The Value of Peripheral Blood Cell Ratios in Primary Membranous Nephropathy: A Single Center Retrospective Study
Aihua Zhang, Guang-Xia Dai, Qidong Zhang et al. (5 authors)
Journal of Inflammation Research
Open Access
Published: Mar 2023
8 citations
8 citations
217 days before retraction
The value of peripheral blood cell ratios in primary membranous nephropathy
Aihua Zhang, Guang-Xia Dai, Qidong Zhang et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Jan 2023
257 days before retraction
Research Progress of Rituximab in the Treatment of Idiopathic Membranous Nephropathy
照玉 杨
Advances in Clinical Medicine
Published: Jan 2023
276 days before retraction
Quick Stats
Total Citations:
7
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025